Bright Minds Biosciences Inc. (DRUG)

Last Closing Price: 76.87 (2026-03-06)

Days Sales in Receivables (Quarterly)

Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover

Bright Minds Biosciences Inc. (DRUG) Days Sales in Receivables data is not available.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
--
$-5.43M
--
--
$4.95M
$-4.95M
$-0.47M
$-5.43M
$-5.43M
$-5.43M
$-5.43M
$-5.43M
$-5.43M
$-4.95M
$-4.94M
7.76M
7.76M
$-0.70
$-0.70
Balance Sheet Financials
$65.12M
--
$0.07M
$65.19M
$1.14M
$0.01M
$0.01M
$1.15M
$64.04M
$64.04M
$64.04M
7.79M
Cash Flow Statement Financials
$-4.17M
--
$9.61M
$59.47M
$63.87M
$4.40M
$0.92M
--
--
Fundamental Metrics & Ratios
57.37
--
--
0.00
0.00
--
--
--
--
--
--
$-4.17M
--
--
--
--
--
--
Days Sales in Receivables
--
-8.47%
-8.47%
-8.32%
-8.47%
$8.22
$-0.54
$-0.54